[HTML] springer.com

[HTML][HTML] Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation

Q Jiang, K Huang, F Lu, S Deng, Z Yang, S Hu - General Thoracic and … - Springer
Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …
被引用次数：22 相关文章

Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation

Q Jiang, K Huang, F Lu, S Deng… - General Thoracic and …, 2022 - search.proquest.com
Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …

Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation.

Q Jiang, K Huang, F Lu, S Deng, Z Yang… - General Thoracic and …, 2021 - europepmc.org
Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …
[HTML] nih.gov

[HTML][HTML] Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation

Q Jiang, K Huang, F Lu, S Deng, Z Yang… - General Thoracic and …, 2022 - ncbi.nlm.nih.gov
Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …

Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation

Q Jiang, K Huang, F Lu, S Deng… - General thoracic and …, 2022 - pubmed.ncbi.nlm.nih.gov
Mesenchymal stem cell (MSC) transplantation is regarded as a promising candidate for the
treatment of ischaemic heart disease. The major hurdles for successful clinical translation of …